Academic Journal
View in EDS
Linked Full Text

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

Bibliographic Details
Title: The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
Authors: Feng‐Hua Wang, Xiao‐Tian Zhang, Lei Tang, Qi Wu, Mu‐Yan Cai, Yuan‐Fang Li, Xiu‐Juan Qu, Hong Qiu, Yu‐Jing Zhang, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Chang Wang, Hao Liu, Miao‐Zhen Qiu, Wen‐Long Guan, Sheng‐Xiang Rao, Jia‐Fu Ji, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Zhi‐Wei Zhou, Ai‐Ping Zhou, Jing Jin, Xiang‐Lin Yuan, Feng Bi, Tian‐Shu Liu, Han Liang, Yan‐Qiao Zhang, Guo‐Xin Li, Jun Liang, Bao‐Rui Liu, Lin Shen, Jin Li, Rui‐Hua Xu
Source: Cancer Communications, Vol 44, Iss 1, Pp 127-172 (2024)
Publisher Information: Wiley, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Chinese Society of Clinical Oncology (CSCO), gastric cancer, diagnosis, surgery, neoadjuvant, adjuvant, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, healthcare resource availability, and precision medicine. These updates address the differences in epidemiological characteristics, clinicopathological features, tumor biology, treatment patterns, and drug selections between Eastern and Western gastric cancer patients. Key revisions include a structured template for imaging diagnosis reports, updated standards for molecular marker testing in pathological diagnosis, and an elevated recommendation for neoadjuvant chemotherapy in stage III gastric cancer. For advanced metastatic gastric cancer, the guidelines introduce new recommendations for immunotherapy, anti‐angiogenic therapy and targeted drugs, along with updated management strategies for human epidermal growth factor receptor 2 (HER2)‐positive and deficient DNA mismatch repair (dMMR)/microsatellite instability‐high (MSI‐H) patients. Additionally, the guidelines offer detailed screening recommendations for hereditary gastric cancer and an appendix listing drug treatment regimens for various stages of gastric cancer. The 2023 CSCO Clinical Guidelines for Gastric Cancer updates are based on both Chinese and international clinical research and expert consensus to enhance their applicability and relevance in clinical practice, particularly in the heterogeneous healthcare landscape of China, while maintaining a commitment to scientific rigor, impartiality, and timely revisions.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2523-3548
Relation: https://doaj.org/toc/2523-3548
DOI: 10.1002/cac2.12516
Access URL: https://doaj.org/article/ddb71d41f751472a92fb64e883303e66
Accession Number: edsdoj.b71d41f751472a92fb64e883303e66
Database: Directory of Open Access Journals
FullText Links:
  – Type: other
    Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=4D1A900BA1E86490BCCF&Show=Object
Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=25233548&ISBN=&volume=44&issue=1&date=20240101&spage=127&pages=127-172&title=Cancer Communications&atitle=The%20Chinese%20Society%20of%20Clinical%20Oncology%20%28CSCO%29%3A%20Clinical%20guidelines%20for%20the%20diagnosis%20and%20treatment%20of%20gastric%20cancer%2C%202023&aulast=Feng%E2%80%90Hua%20Wang&id=DOI:10.1002/cac2.12516
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/ddb71d41f751472a92fb64e883303e66
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.b71d41f751472a92fb64e883303e66
RelevancyScore: 1020
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1020.37725830078
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Feng‐Hua+Wang%22">Feng‐Hua Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Xiao‐Tian+Zhang%22">Xiao‐Tian Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Lei+Tang%22">Lei Tang</searchLink><br /><searchLink fieldCode="AR" term="%22Qi+Wu%22">Qi Wu</searchLink><br /><searchLink fieldCode="AR" term="%22Mu‐Yan+Cai%22">Mu‐Yan Cai</searchLink><br /><searchLink fieldCode="AR" term="%22Yuan‐Fang+Li%22">Yuan‐Fang Li</searchLink><br /><searchLink fieldCode="AR" term="%22Xiu‐Juan+Qu%22">Xiu‐Juan Qu</searchLink><br /><searchLink fieldCode="AR" term="%22Hong+Qiu%22">Hong Qiu</searchLink><br /><searchLink fieldCode="AR" term="%22Yu‐Jing+Zhang%22">Yu‐Jing Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Jie‐Er+Ying%22">Jie‐Er Ying</searchLink><br /><searchLink fieldCode="AR" term="%22Jun+Zhang%22">Jun Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Ling‐Yu+Sun%22">Ling‐Yu Sun</searchLink><br /><searchLink fieldCode="AR" term="%22Rong‐Bo+Lin%22">Rong‐Bo Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Chang+Wang%22">Chang Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Hao+Liu%22">Hao Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Miao‐Zhen+Qiu%22">Miao‐Zhen Qiu</searchLink><br /><searchLink fieldCode="AR" term="%22Wen‐Long+Guan%22">Wen‐Long Guan</searchLink><br /><searchLink fieldCode="AR" term="%22Sheng‐Xiang+Rao%22">Sheng‐Xiang Rao</searchLink><br /><searchLink fieldCode="AR" term="%22Jia‐Fu+Ji%22">Jia‐Fu Ji</searchLink><br /><searchLink fieldCode="AR" term="%22Yan+Xin%22">Yan Xin</searchLink><br /><searchLink fieldCode="AR" term="%22Wei‐Qi+Sheng%22">Wei‐Qi Sheng</searchLink><br /><searchLink fieldCode="AR" term="%22Hui‐Mian+Xu%22">Hui‐Mian Xu</searchLink><br /><searchLink fieldCode="AR" term="%22Zhi‐Wei+Zhou%22">Zhi‐Wei Zhou</searchLink><br /><searchLink fieldCode="AR" term="%22Ai‐Ping+Zhou%22">Ai‐Ping Zhou</searchLink><br /><searchLink fieldCode="AR" term="%22Jing+Jin%22">Jing Jin</searchLink><br /><searchLink fieldCode="AR" term="%22Xiang‐Lin+Yuan%22">Xiang‐Lin Yuan</searchLink><br /><searchLink fieldCode="AR" term="%22Feng+Bi%22">Feng Bi</searchLink><br /><searchLink fieldCode="AR" term="%22Tian‐Shu+Liu%22">Tian‐Shu Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Han+Liang%22">Han Liang</searchLink><br /><searchLink fieldCode="AR" term="%22Yan‐Qiao+Zhang%22">Yan‐Qiao Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Guo‐Xin+Li%22">Guo‐Xin Li</searchLink><br /><searchLink fieldCode="AR" term="%22Jun+Liang%22">Jun Liang</searchLink><br /><searchLink fieldCode="AR" term="%22Bao‐Rui+Liu%22">Bao‐Rui Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Lin+Shen%22">Lin Shen</searchLink><br /><searchLink fieldCode="AR" term="%22Jin+Li%22">Jin Li</searchLink><br /><searchLink fieldCode="AR" term="%22Rui‐Hua+Xu%22">Rui‐Hua Xu</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Cancer Communications, Vol 44, Iss 1, Pp 127-172 (2024)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Wiley, 2024.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2024
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Chinese+Society+of+Clinical+Oncology+%28CSCO%29%22">Chinese Society of Clinical Oncology (CSCO)</searchLink><br /><searchLink fieldCode="DE" term="%22gastric+cancer%22">gastric cancer</searchLink><br /><searchLink fieldCode="DE" term="%22diagnosis%22">diagnosis</searchLink><br /><searchLink fieldCode="DE" term="%22surgery%22">surgery</searchLink><br /><searchLink fieldCode="DE" term="%22neoadjuvant%22">neoadjuvant</searchLink><br /><searchLink fieldCode="DE" term="%22adjuvant%22">adjuvant</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Abstract The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, healthcare resource availability, and precision medicine. These updates address the differences in epidemiological characteristics, clinicopathological features, tumor biology, treatment patterns, and drug selections between Eastern and Western gastric cancer patients. Key revisions include a structured template for imaging diagnosis reports, updated standards for molecular marker testing in pathological diagnosis, and an elevated recommendation for neoadjuvant chemotherapy in stage III gastric cancer. For advanced metastatic gastric cancer, the guidelines introduce new recommendations for immunotherapy, anti‐angiogenic therapy and targeted drugs, along with updated management strategies for human epidermal growth factor receptor 2 (HER2)‐positive and deficient DNA mismatch repair (dMMR)/microsatellite instability‐high (MSI‐H) patients. Additionally, the guidelines offer detailed screening recommendations for hereditary gastric cancer and an appendix listing drug treatment regimens for various stages of gastric cancer. The 2023 CSCO Clinical Guidelines for Gastric Cancer updates are based on both Chinese and international clinical research and expert consensus to enhance their applicability and relevance in clinical practice, particularly in the heterogeneous healthcare landscape of China, while maintaining a commitment to scientific rigor, impartiality, and timely revisions.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2523-3548
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/2523-3548
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1002/cac2.12516
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/ddb71d41f751472a92fb64e883303e66" linkWindow="_blank">https://doaj.org/article/ddb71d41f751472a92fb64e883303e66</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.b71d41f751472a92fb64e883303e66
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.b71d41f751472a92fb64e883303e66
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cac2.12516
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 46
        StartPage: 127
    Subjects:
      – SubjectFull: Chinese Society of Clinical Oncology (CSCO)
        Type: general
      – SubjectFull: gastric cancer
        Type: general
      – SubjectFull: diagnosis
        Type: general
      – SubjectFull: surgery
        Type: general
      – SubjectFull: neoadjuvant
        Type: general
      – SubjectFull: adjuvant
        Type: general
      – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
        Type: general
      – SubjectFull: RC254-282
        Type: general
    Titles:
      – TitleFull: The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feng‐Hua Wang
      – PersonEntity:
          Name:
            NameFull: Xiao‐Tian Zhang
      – PersonEntity:
          Name:
            NameFull: Lei Tang
      – PersonEntity:
          Name:
            NameFull: Qi Wu
      – PersonEntity:
          Name:
            NameFull: Mu‐Yan Cai
      – PersonEntity:
          Name:
            NameFull: Yuan‐Fang Li
      – PersonEntity:
          Name:
            NameFull: Xiu‐Juan Qu
      – PersonEntity:
          Name:
            NameFull: Hong Qiu
      – PersonEntity:
          Name:
            NameFull: Yu‐Jing Zhang
      – PersonEntity:
          Name:
            NameFull: Jie‐Er Ying
      – PersonEntity:
          Name:
            NameFull: Jun Zhang
      – PersonEntity:
          Name:
            NameFull: Ling‐Yu Sun
      – PersonEntity:
          Name:
            NameFull: Rong‐Bo Lin
      – PersonEntity:
          Name:
            NameFull: Chang Wang
      – PersonEntity:
          Name:
            NameFull: Hao Liu
      – PersonEntity:
          Name:
            NameFull: Miao‐Zhen Qiu
      – PersonEntity:
          Name:
            NameFull: Wen‐Long Guan
      – PersonEntity:
          Name:
            NameFull: Sheng‐Xiang Rao
      – PersonEntity:
          Name:
            NameFull: Jia‐Fu Ji
      – PersonEntity:
          Name:
            NameFull: Yan Xin
      – PersonEntity:
          Name:
            NameFull: Wei‐Qi Sheng
      – PersonEntity:
          Name:
            NameFull: Hui‐Mian Xu
      – PersonEntity:
          Name:
            NameFull: Zhi‐Wei Zhou
      – PersonEntity:
          Name:
            NameFull: Ai‐Ping Zhou
      – PersonEntity:
          Name:
            NameFull: Jing Jin
      – PersonEntity:
          Name:
            NameFull: Xiang‐Lin Yuan
      – PersonEntity:
          Name:
            NameFull: Feng Bi
      – PersonEntity:
          Name:
            NameFull: Tian‐Shu Liu
      – PersonEntity:
          Name:
            NameFull: Han Liang
      – PersonEntity:
          Name:
            NameFull: Yan‐Qiao Zhang
      – PersonEntity:
          Name:
            NameFull: Guo‐Xin Li
      – PersonEntity:
          Name:
            NameFull: Jun Liang
      – PersonEntity:
          Name:
            NameFull: Bao‐Rui Liu
      – PersonEntity:
          Name:
            NameFull: Lin Shen
      – PersonEntity:
          Name:
            NameFull: Jin Li
      – PersonEntity:
          Name:
            NameFull: Rui‐Hua Xu
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 25233548
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer Communications
              Type: main
ResultId 1